Steve Downes is a global quality and compliance leader with over 20 years of leadership experience in the pharmaceutical, biotech, and medtech industries. He has held senior roles at companies including Takeda, Ascensia Diabetes Care, and Pall Corporation, leading major global quality transformations and driving operational excellence across complex, regulated environments. His core expertise spans GMP, regulatory strategy, risk management, and organizational change. Known for delivering measurable impact, Steve has implemented global quality systems, strengthened audit readiness, and elevated supplier and stakeholder engagement. Steve is Co-Founder and President of the Basel Pharma Networking Group, fostering collaboration and knowledge exchange within the life sciences community. He currently works as an independent consultant, supporting quality leadership and transformation with strategic clarity and practical execution.
